*Schedule by Topic - Nursing, Health Sciences and Allied Health (NHSAH)


 

Tuesday, April 2, 2019

 

7:45 AM – 6:15 PM

 

Wednesday, April 3, 2019

 

12:30 PM - 1:45 PM

COUNCIL MEETING: Nursing, Health Sciences and Allied Health (Pacifica 3-5)
 

2:00 PM – 3:45 PM

Visit the ISHLT2019 Online Program Viewer to see the full details for this session

Primary Audience: NHSAH
Secondary Audience: MCS, PEDS

Session Summary: A successful discharge for patients with VAD or other supportive therapies (continuous infusions for pulmonary hypertension and heart failure patients) requires thoughtful planning and education. This symposium addresses topics geared towards helping patients successfully discharge to (and remain) home, including self-management/self-efficacy, discharge medications, avoiding readmission, preparing caregivers of patients with devices, and addressing the issues most important to patients: driving, showering, drinking, sex and traveling.

Chairs: Sarah E. Schroeder, ACNP-BC, MSN, RN, AACC and Mark E. Puhlman, DNP, ANP-C
 
2:00 PM I Can Go the Distance: Building Self Care and Self-Empowerment in Patients
Jesus Casida, PhD, RN, University of Michigan, Ann Arbor, MI, USA
2:15 PM Q&A
2:20 PM You’ve Got a Friend in Me: Preparing Caregivers
Jodie Lantz, MSN, RN, PCNS-BC, Children's Health Dallas, Richardson, TX, USA
2:35 PM Q&A
2:40 PM A Spoonful of Sugar Makes the Discharge Medications Go Down
Cassandra Vale, PharmD, The Prince Charles Hospital, Queensland, Australia
2:55 PM Q&A
3:00 PM How Far I’ll Go: Preventing Returns to the Hospital
Nicola Robinson Smith, RN, Freeman Hospital, Newcastle Upon Tyne, UK
3:15 PM Q&A
3:20 PM The Bare Necessities: The Do's and Don’ts of Living with a New Device
Wendy Gin-Sing, CNS, Hammersmith Hospital, London, UK
3:35 PM Q&A
 

6:00 PM –7:15 PM

Nursing, Health Sciences & Allied Health (Gardenia 2)
Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Nursing, Health Sciences, Allied Health (Gardenia 2)
(NHSAH)   Poster Numbers: 738-754
 

Thursday April 4, 2019

 
Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Primary Audience: NHSAH
Secondary Audience: HTX, LTX, PEDS, PHARM

Chairs:Flavio R. Epstein, PhD and Melissa Sanchez, BScHons, PGDip, MSc, DClinPSy
 
4:00 PM (203) Intravenous Methamphetamine Does Not Appear to Be a Contraindication for Heart Donation in Heart Transplantation
A. Velleca, T. Kao, B. Kearney, J. Patel, M. Kittleson, R. Levine, S. Dimbil, S. Mersola, M. Hamilton, F. Esmailian, J. Kobashigawa. Smidt Heart Institute at Cedars-Sinai, Los Angeles, CA
4:15 PM (204) Donor Family and Recipient Anonymity: Time for Change
J. Poole1, M. Shildrick2, S. Abbey3, I. Bachmann4, A. Carnie5, D. Dal Bo4, E. De Luca6, T. El-Sheikh7, E. Jan4, P. McKeever8, A. Wright9, H. Ross6. 1Faculty of Community Services, School of Social Work, Ryerson University, Toronto, ON, Canada, 2Tema Genus, Tema Institute, Linkopings Universitet, Linkopings, Sweden, 3Department of Psychiatry, University Health Network, Toronto, ON, Canada, 4Department of Studio Arts, Faculty of Fine Arts, Concordia University, Montreal, QC, Canada, 5Winchester School of Art, Southampton University, Winchester, United Kingdom, 6Department of Cardiology, University Health Network, Toronto, ON, Canada, 7Department of Art History, Faculty of Fine Arts, Concordia University, Montreal, QC, Canada, 8Bloorview Research Institute, Holland Bloorview Kids Rehabilitation Hospital, Toronto, ON, Canada, 9Department of English, Linguistics and Cultural Studies, University of Westminster, London, United Kingdom
4:30 PM (205) Universal Depression Screen of Ambulatory Cardiac Transplant Recipients is Feasible and Identifies a Subset of Patients That May Benefit from Mental Health Intervention
L. Peters, L. Rosenthal, H. Monroe, M. Dierks, A. Ambardekar, C. McIlvennan. University of Colorado, Aurora, CO
4:45 PM (206) Depressive Symptoms, Physical Activity, and Post-Transplant Outcomes: The ADAPT Prospective Study
P. J. Smith, C. Frankel, D. Bacon, E. Bush, L. Snyder. Duke University Medical Center, Durham, NC
5:00 PM (207) PTSD in Tx ICU Nurses
M. Sanchez1, A. Simon2, D. Ford1. 1Psychological Medicine, Royal Brompton & Harefield NHS Foundation Trust, Harefield, Middlesex, United Kingdom, 2MCS and Cardiothoracic Transplantation, Royal Brompton & Harefield NHS Foundation Trust, Harefield, Middlesex, United Kingdom
5:15 PM (208) Illness Specific Anxiety Following Pediatric Heart Transplant
A. D. McCormick, K. R. Schumacher, M. Zamberlan, K. Uzark, S. Yu, R. Lowery, N. Rottach, M. K. Cousino. Department of Pediatrics, Michigan Medicine, Ann Arbor, MI
5:30 PM (209) The Value of Licensed Clinical Social Worker Pre-Implant Assessment in Predicting Non-Compliance in Durable Mechanical Circulatory Support Device Patients
H. Barone1, M. Olman2, A. Fishman2, L. Olanisa2, C. Runyan1, J. Hajj1, N. Huie1, M. Lindsay1, E. Passano1, J. Kobashigawa1, J. Moriguchi1, R. Cole1, F. Esmailian1, J. Chung1, D. Ramzy1. 1Smidt Heart Institute at Cedars-Sinai, Los Angeles, CA, 2Cedars-Sinai Medical Center, Los Angeles, CA
 

6:00 PM – 7:00 PM

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Primary Audience: NHSAH
Secondary Audience: HTX, LTX, PEDS, PHARM

Chairs: Donna Hickling and Kyle L. Dawson, PharmD, MBA, BCPS
 
6:00 PM (465) Associations between Self-Reported Physical Function and Exercise Capacity in De Novo Heart Transplant Recipients
K. Rolid1, A. K. Andreassen1, M. Yardley1, E. Gude1, E. Bjørkelund1, A. R. Authen1, I. Grov1, K. I. Pettersen1, C. Dall2, E. Prescott2, K. Karason3, L. Gullestad1, K. Nytrøen1. 1Department of Cardiology, Oslo University Hospital,Rikshospitalet, Oslo, Norway, 2Department of Cardiology, Bispebjerg University Hospital, Copenhagen, Denmark, 3Department of Cardiology, Sahlgrenska University Hospital, Gothenborg, Sweden
6:05 PM (466) Effect of High Intensity Interval Training on Health Related Quality of Life in De Novo Heart Transplant Recipients-The HITTS Study
K. Rolid1, A. K. Andreassen1, M. Yardley1, E. Gude1, E. Bjørkelund1, A. R. Authen1, I. Grov1, K. I. Pettersen1, C. H. Dall2, E. Prescott2, K. Karason3, L. Gullestad1, K. Nytrøen1. 1Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway, 2Department of Cardiology, Bispebjerg University Hospital, Copenhagen, Denmark, 3Department of Cardiology, Sahlgrenska University Hospital, Gothenborg, Sweden
6:10 PM (467) Pre Transplant Quadriceps Strength is a Modifiable Predictor of Functional Outcomes Following Lung Transplantation
J. R. Walsh1, D. C. Chambers2, S. T. Yerkovich2, N. R. Morris3, P. M. Hopkins2. 1Physiotherapy, The Prince Charles Hospital, Brisbane, Australia, 2Queensland Lung Transplant Unit, The Prince Charles Hospital, Brisbane, Australia, 3School of Allied Health Sciences, Griffith University, Gold Coast, Australia
6:15 PM (468) What Happens to Frailty in the First Year after Lung Transplantation?
L. M. Fuller1, H. Whitford2, Y. Cristiano2, R. Robinson1, R. Steward1, M. Poulsen1, W. Shi3, G. M. Snell4. 1Physiotherapy, Alfred Hospital, Melbourne, Australia, 2Respiratory Unit, Alfred Hospital, Melbourne, Australia, 3Cardiothoracic Surgery, Alfred Hospital, Melbourne, Australia, 4Lung Transplant Unit, Alfred Hospital, Melbourne, Australia
6:20 PM (469) QOLVAD Detects Changes in Emotional, Social, Cognitive and Physical Wellbeing after Continuous-Flow LVAD Implant
J. A. Cowger1, C. S. Lee2, P. Eckman3, R. Garberich4, C. Weaver5, S. Joseph6, S. Hall6, S. Carrie7, S. Chaudhry8, S. E. Schroeder9, R. O. Hoffman, III10, D. Feldman11, G. Conway12, E. Y. Birati13, M. Soni14, J. Marble15, K. M. Faulkner2, K. E. Sandau16. 1Cardiovascular Medicine, HF/Transplant/MCS, Henry Ford Hospital, Detroit, MI, 2Boston College Connell School of Nursing, Boston, MA, 3Cardiovascular Medicine, HF/Transplant/MCS, Minneapolis Heart Institute at Abbott Northwestern Hospital, Minneapolis, MN, 4Minneapolis Heart Institute Foundation, Minneapolis, MN, 5Cardiovascular Medicine, HF/Transplant/MCS, Abbott Northwestern Hospital/Minneapolis Heart Institute, Minneapolis, MN, 6Cardiovascular Medicine, HF/Transplant/MCS, Baylor University Medical Center, Dallas, TX, 7Baylor University Medical Center, Dallas, TX, 8Cardiovascular Medicine, HF/Transplant/MCS, Ascension Hospital/St Vincent, Indianapolis, IN, 9Bryan Heart Center, Lincoln, NE, 10University of Cincinnati Medical Center, Cincinnati, OH, 11Cardiovascular Medicine, HF/Transplant/MCS, University of Cincinnati Medical Center, Cincinnati, OH, 12Division of Cardiovascular Health and Disease, University of Cincinnati Medical Center, Cincinnati, OH, 13Cardiovascular Medicine, HF/Transplant/MCS, Perelman School of Medicine, University of Pennsylvania, Philidelphia, PA, 14Department of Medicine, University of Pennsylvania, Philidelphia, PA, 15Cardiovascular Medicine, HF/Transplant/MCS, University of Pennsylvania, Philidelphia, PA, 16Cardiovascular Medicine, Bethel University; Allina Health, Minneapolis, MN
6:25 PM (470) Lack of Social Support is Not a Contraindication to VAD Therapy
N. Robinson Smith1, E. Sowerby2, J. Meadows2, S. Tovey Brown3, A. Woods1, G. MacGowan1, S. Schueler1. 1MCS Service Cardio Thoracic, Newcastle upon Tyne Hospital NHS Trust, Newcastle upon Tyne, United Kingdom, 2Social Work, Newcastle upon Tyne Hospital NHS Trust, Newcastle upon Tyne, United Kingdom, 3MCS Service Cardiothoracic, Newcastle upon Tyne Hospital NHS Trust, Newcastle upon Tyne, United Kingdom
6:30 PM (471) It Takes a Village: Pediatric Ventricular Assist Device Training and Education Practices among ACTION Centers
K. Fields1, B. Hawkins2, J. Lantz3, M. Mehegan4, J. Murray5, L. Burkhart1, C. Villa1. 1Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Boston Children's Hospital, Boston, MA, 3Children's Medical Center Dallas, Dallas, TX, 4St. Louis Children's Hospital, Saint Louis, MO, 5Lucille Packard Children's Hospital, Palo Alto, CA
6:35 PM (472) Lung Transplant Clinicians’ Perceptions of Pocket PATH Synergy, an Interactive Health Technology (IHT) to Monitor Patients Remotely
A. J. Devito Dabbs1, T. Irizarry1, M. Alrawashdeh1, J. M. Pilewski2, M. Morrell2, J. D'Cunha2, M. Dew2. 1University of Pittsburgh School of Nursing, Pittsburgh, PA, 2University of Pittsburgh School of Medicine, Pittsburgh, PA
6:40 PM (473) Pre-Lung Transplant Waitlist Mortality Rate Reduction Using Remote Video Monitoring Technology
M. Zubrinic1, N. Marks2, L. Brzozowski3, J. Qiu3, D. Lin3, K. Wang3, J. De Romana1, L. Singer4, S. Keshavjee1. 1Department of Surgery, University Health Network, Toronto, ON, Canada, 2Multi-Organ Transplant Program, University Health Network, Toronto, ON, Canada, 3Techna Institute & University Health Network, Toronto, ON, Canada, 4Division of Respirology, Department of Medicine, University Health Network, Toronto, ON, Canada
 

Friday, April 5, 2019

 

7:00 AM – 8:00 AM

Visit the ISHLT2019 Online Program Viewer to see the full details for this session

Primary Audience: NHSAH

Session Summary: Research has led to incredible advancements in organ failure/transplant outcomes. Despite its significance, not all transplant professionals have training or experience in the conduct of research. Launching (or continuing) a program of research can be intimidating for many. Experts in the field will provide guidance on the conduct of research from study development to dissemination findings. Tips for funding one's research will also be shared.

Chairs: Mary Amanda Dew, PhD and Sarah Schettle, PA-C
 
7:00 AM Don’t Go Rogue: Planning and Launching a Research Study
Pamela Combs, PhD, RN, University of Chicago, Chicago, IL, USA
7:15 AM The Fallout: Dissemination and Sharing your Results
Desiree Robson, RN BSc (Hons), St. Vincent’s Hospital, Sydney, Australia
7:30 AM The Ghost Hunt: Funding Your Research
Kathleen L. Grady, PhD, APN, FAAN, Northwestern Memorial Hospital, Chicago, IL, USA
7:45 AM 15-min Panel Discussion
 

4:15 PM – 6:00 PM

Visit the ISHLT2019 Online Program Viewer to see the full details for this session

Primary Audience: NHSAH
Secondary Audience: PEDS, PH, PHARM

Session Summary: This symposium will include novel talks to advance the ways in which we care for organ failure/transplant patients at end of life (EOL). Covered topics will include: emotional support for patients at EOL, collaboration with ethics and palliative care teams, pharmacological management of patients at EOL, palliative care for the pediatric and adult congenital heart disease population, religious/cultural diversity in EOL, and addressing provider burn-out/self-care.

Chairs: Melissa Cousino, PhD, and Rachel M. Crackett, MSc
 
4:15 PM Beyond Life Support: Emotional Support for Patients at End of Life
Bronwyn J. Levvey, RN, Grad Dip Clin Ep, Alfred Hospital, Melbourne, Australia
4:30 PM It's Complicated: Collaboration and Integration Between Palliative Care, Ethics and Transplant Teams
Andrew Courtwright, MD, PhD, University of Pennsylvania, Philadelphia, PA, USA
4:45 PM Pharmacological Management of the MCS/Transplant Patient at End of Life
Steven P. Ivulich, BPharm, Alfred Hospital, Melbourne, Australia
5:00 PM Bringing PC to PEDS: Palliative Care for Pediatric Transplant and MCS Patients
Elizabeth Blume, MD, Children's Hospital, Boston, MA, USA
5:15 PM Bridging the Gaps: Cultural and Regional Diversity and End of Life Care
Rachel Hadler, MD, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
5:30 PM Self-Care for Us! Provider Heartbreak in Organ Failure/Transplant Care
Julie Bidwell, PhD, Emory University, Atlanta, GA, USA
5:45 PM 15-min Panel Discussion
 

Saturday, April 6, 2019

 

7:00 AM – 8:00 AM

Visit the ISHLT2019 Online Program Viewer to see the full details for this session

Primary Audience: NHSAH
Secondary Audience: HF/HTX, LF/LTX, MCS

Session Summary: A multi-disciplinary approach to the assessment and treatment of a complex frail patient will be highlighted. A case study describing a patient with end stage disease will be presented who is experiencing nutritional, cognitive, and mental health concerns. Individual talks addressing these issues will be from a physician, psychologist, and dietitian. The symposium will conclude by involving the audience in an open discussion on issues raised in one's clinical experience with frail patients.

Chairs: Louise M. Fuller, PT and Rose DeRosa, PA-C
 
7:00 AM Dying, Not Necessarily Doomed
Oscar Gonzalez Fernandez, MD, Hospital Universitario La Paz, Madrid, Spain
7:15 AM Cognitive Deficits, Not Necessarily Crazy
Patrick J. Smith, PhD, MPH, Duke University Medical Center, Durham, NC, USA
7:30 AM Withered, Not Necessarily Wasted
Kirsten Diegel, RD, LDN, Temple University Hospital, Philadelphia, PA, USA
7:45 AM 15-min Panel Discussion




*This schedule at a glance is updated each Friday to reflect any changes in information, including room names, session times, speaker information